Vault-13

Sofinnova Investments, Inc.

Menlo Park, CA · CIK 1631134 · 13F filing filed 2026-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

As an employer

US visa salary filings

Job titleFilingsMedianRange
Financial AnalystMenlo Park, CA 1 $150,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Sofinnova Investments, Inc..

$1.9bn reported value -6.2% vs Q1 2026
53positions
59.8%in top 10
11 new 12 added 17 reduced 19 sold out vs Q1 2026

Options: 3 call positions ($48.4m notional), 1 put positions ($13.8m notional) – listed below, not included above.

Holdings, Q2 2026

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 NATERA INC COM NTRA NTRA 1,550,280 $420.8m22.48% 22.48% UnchangedShares held: Q3 2025 1.6m, Q4 2025 1.6m, Q1 2026 1.6m, Q2 2026 1.6m
2 VERA THERAPEUTICS INC CL A VERA VERA 2,793,987 $119.9m6.40% 6.40% UnchangedShares held: Q3 2025 2.8m, Q4 2025 2.8m, Q1 2026 2.8m, Q2 2026 2.8m
3 GENMAB A/S SPONSORED ADS GMAB GMAB 4,045,215 $111.1m5.94% 5.94% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 752.3k, Q2 2026 4.0m +3.3m +3,292,954 437.7%
4 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 365,341 $88.0m4.70% 4.70% ReducedShares held: Q3 2025 588.8k, Q4 2025 959.9k, Q1 2026 598.3k, Q2 2026 365.3k -233.0k -232,986 -38.9%
5 RAPPORT THERAPEUTICS INC COM RAPP RAPP 1,904,408 $79.4m4.24% 4.24% UnchangedShares held: Q3 2025 1.9m, Q4 2025 1.9m, Q1 2026 1.9m, Q2 2026 1.9m
6 SEAPORT THERAPEUTICS INC COMMON STOCK SPTX SPTX 3,564,871 $77.4m4.14% 4.14% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 3.6m
7 ARRIVENT BIOPHARMA INC COM AVBP AVBP 1,696,752 $58.9m3.15% 3.15% UnchangedShares held: Q3 2025 1.7m, Q4 2025 1.7m, Q1 2026 1.7m, Q2 2026 1.7m
8 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 1,717,505 $57.3m3.06% 3.06% ReducedShares held: Q3 2025 0, Q4 2025 83.3k, Q1 2026 3.1m, Q2 2026 1.7m -1.4m -1,428,383 -45.4%
9 BIOAGE LABS INC COM BIOA BIOA 2,293,788 $56.2m3.00% 3.00% UnchangedShares held: Q3 2025 2.3m, Q4 2025 2.3m, Q1 2026 2.3m, Q2 2026 2.3m
10 BRISTOL-MYERS SQUIBB CO COM BMY BMY 876,970 $50.5m2.70% 2.70% ReducedShares held: Q3 2025 0, Q4 2025 1.5m, Q1 2026 2.0m, Q2 2026 877.0k -1.1m -1,111,751 -55.9%
11 SUPERNUS PHARMACEUTICALS INC COM SUPN SUPN 1,036,328 $48.2m2.57% 2.57% AddedShares held: Q3 2025 377.1k, Q4 2025 553.1k, Q1 2026 954.3k, Q2 2026 1.0m +82.0k +82,019 8.6%
12 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 408,027 $45.3m2.42% 2.42% ReducedShares held: Q3 2025 247.0k, Q4 2025 271.4k, Q1 2026 450.1k, Q2 2026 408.0k -42.1k -42,069 -9.3%
13 GILEAD SCIENCES INC COM GILD GILD 343,100 $43.3m2.32% 2.32% NewShares held: Q3 2025 1.3m, Q4 2025 0, Q1 2026 0, Q2 2026 343.1k
14 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 76,489 $41.4m2.21% 2.21% ReducedShares held: Q3 2025 190.6k, Q4 2025 157.6k, Q1 2026 160.1k, Q2 2026 76.5k -83.6k -83,581 -52.2%
15 COGENT BIOSCIENCES INC COM COGT COGT 1,035,148 $40.1m2.14% 2.14% ReducedShares held: Q3 2025 2.1m, Q4 2025 2.0m, Q1 2026 2.1m, Q2 2026 1.0m -1.1m -1,078,403 -51.0%
16 AXSOME THERAPEUTICS INC COM AXSM AXSM 160,429 $39.3m2.10% 2.10% ReducedShares held: Q3 2025 393.5k, Q4 2025 12.3k, Q1 2026 212.7k, Q2 2026 160.4k -52.3k -52,318 -24.6%
17 IMMATICS N.V SHS IMTX IMTX 3,669,346 $37.2m1.99% 1.99% AddedShares held: Q3 2025 2.2m, Q4 2025 3.4m, Q1 2026 3.6m, Q2 2026 3.7m +38.9k +38,892 1.1%
18 DYNE THERAPEUTICS INC COM DYN DYN 1,658,384 $36.8m1.97% 1.97% AddedShares held: Q3 2025 985.8k, Q4 2025 2.3m, Q1 2026 1.6m, Q2 2026 1.7m +24.5k +24,487 1.5%
19 IMMUNOME INC COM IMNM IMNM 1,720,316 $36.5m1.95% 1.95% AddedShares held: Q3 2025 436.1k, Q4 2025 1.6m, Q1 2026 1.7m, Q2 2026 1.7m +18.4k +18,412 1.1%
20 IDEAYA BIOSCIENCES INC COM IDYA IDYA 925,119 $34.5m1.84% 1.84% ReducedShares held: Q3 2025 922.7k, Q4 2025 885.1k, Q1 2026 1.1m, Q2 2026 925.1k -206.7k -206,667 -18.3%
21 ANAPTYSBIO INC COM ANAB ANAB 493,536 $33.3m1.78% 1.78% AddedShares held: Q3 2025 254.3k, Q4 2025 287.7k, Q1 2026 248.3k, Q2 2026 493.5k +245.3k +245,283 98.8%
22 NEKTAR THERAPEUTICS COM NEW NKTR NKTR 471,763 $32.9m1.76% 1.76% ReducedShares held: Q3 2025 118.4k, Q4 2025 438.6k, Q1 2026 509.5k, Q2 2026 471.8k -37.8k -37,783 -7.4%
23 PHARVARIS N V COM PHVS PHVS 881,299 $30.5m1.63% 1.63% AddedShares held: Q3 2025 739.9k, Q4 2025 745.2k, Q1 2026 818.3k, Q2 2026 881.3k +63.0k +62,971 7.7%
24 ARCUS BIOSCIENCES INC COM RCUS RCUS 945,690 $29.2m1.56% 1.56% AddedShares held: Q3 2025 1.2m, Q4 2025 1.1m, Q1 2026 923.1k, Q2 2026 945.7k +22.6k +22,604 2.5%
25 INHIBRX BIOSCIENCES INC COM INBX INBX 303,103 $28.7m1.53% 1.53% ReducedShares held: Q3 2025 440.1k, Q4 2025 454.7k, Q1 2026 406.0k, Q2 2026 303.1k -102.9k -102,926 -25.4%
26 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 358,568 $20.5m1.10% 1.10% ReducedShares held: Q3 2025 0, Q4 2025 697.1k, Q1 2026 782.0k, Q2 2026 358.6k -423.4k -423,414 -54.1%
27 VERADERMICS INC COMMON STOCK MANE MANE 148,993 $18.3m0.98% 0.98% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 73.3k, Q2 2026 149.0k +75.7k +75,678 103.2%
28 ALCON AG ORD SHS ALC ALC 255,824 $17.2m0.92% 0.92% ReducedShares held: Q3 2025 0, Q4 2025 332.5k, Q1 2026 730.0k, Q2 2026 255.8k -474.1k -474,148 -65.0%
29 INSMED INC COM PAR $.01 INSM INSM 158,398 $16.9m0.90% 0.90% ReducedShares held: Q3 2025 104.3k, Q4 2025 156.8k, Q1 2026 346.1k, Q2 2026 158.4k -187.7k -187,677 -54.2%
30 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 380,923 $15.5m0.83% 0.83% ReducedShares held: Q3 2025 520.2k, Q4 2025 437.8k, Q1 2026 386.5k, Q2 2026 380.9k -5.6k -5,575 -1.4%
31 NURIX THERAPEUTICS INC COM NRIX NRIX 524,098 $12.7m0.68% 0.68% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 524.1k
32 DESIGN THERAPEUTICS INC COM DSGN DSGN 865,135 $12.5m0.67% 0.67% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 865.1k
33 DEFINIUM THERAPEUTICS INC COM SHS DFTX DFTX 255,903 $12.0m0.64% 0.64% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 344.2k, Q2 2026 255.9k -88.3k -88,263 -25.6%
34 FIRST TRACKS BIOTHERAPEUTICS ORD SHS TRAX TRAX 565,199 $11.4m0.61% 0.61% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 565.2k
35 ABBOTT LABS COM ABT ABT 122,998 $11.2m0.60% 0.60% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 123.0k
36 DISC MEDICINE INC COM IRON IRON 146,239 $10.7m0.57% 0.57% AddedShares held: Q3 2025 13.6k, Q4 2025 111.0k, Q1 2026 78.3k, Q2 2026 146.2k +67.9k +67,919 86.7%
37 TENAX THERAPEUTICS INC COM NEW TENX TENX 500,039 $7.3m0.39% 0.39% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 104.4k, Q2 2026 500.0k +395.6k +395,639 379.0%
38 SIONNA THERAPEUTICS INC COM SION SION 144,432 $6.4m0.34% 0.34% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 144.4k
39 ABSCI CORPORATION COM ABSI ABSI 337,400 $3.9m0.21% 0.21% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 337.4k
40 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 27,591 $3.2m0.17% 0.17% UnchangedShares held: Q3 2025 0, Q4 2025 23.1k, Q1 2026 27.6k, Q2 2026 27.6k
41 JADE BIOSCIENCES INC COM NEW JBIO JBIO 107,391 $2.4m0.13% 0.13% UnchangedShares held: Q3 2025 107.4k, Q4 2025 107.4k, Q1 2026 107.4k, Q2 2026 107.4k
42 SAVARA INC COM SVRA SVRA 364,763 $2.2m0.12% 0.12% UnchangedShares held: Q3 2025 2.4m, Q4 2025 304.8k, Q1 2026 364.8k, Q2 2026 364.8k
43 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 6,440 $2.2m0.12% 0.12% ReducedShares held: Q3 2025 172.8k, Q4 2025 125.7k, Q1 2026 63.7k, Q2 2026 6.4k -57.2k -57,240 -89.9%
44 SEPTERNA INC COM SEPN SEPN 47,506 $1.6m0.08% 0.08% UnchangedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 47.5k, Q2 2026 47.5k
45 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 321,692 $1.5m0.08% 0.08% AddedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 141.7k, Q2 2026 321.7k +180.0k +179,992 127.0%
46 SAGIMET BIOSCIENCES INC COM SER A SGMT SGMT 166,667 $1.3m0.07% 0.07% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 166.7k
47 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 189,253 $1.1m0.06% 0.06% UnchangedShares held: Q3 2025 170.9k, Q4 2025 158.2k, Q1 2026 189.3k, Q2 2026 189.3k
48 AKTIS ONCOLOGY INC COM AKTS AKTS 32,436 $1.0m0.06% 0.06% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 32.4k
49 TYRA BIOSCIENCES INC COM TYRA TYRA 32,267 $1.0m0.06% 0.06% ReducedShares held: Q3 2025 0, Q4 2025 0, Q1 2026 204.0k, Q2 2026 32.3k -171.7k -171,748 -84.2%
50 BOLT BIOTHERAPEUTICS INC COM NEW BOLT BOLT 137,721 $530.2k0.03% 0.03% UnchangedShares held: Q3 2025 137.7k, Q4 2025 137.7k, Q1 2026 137.7k, Q2 2026 137.7k
51 NEXTCURE INC COM NEW NXTC NXTC 222,654 $356.2k0.02% 0.02% UnchangedShares held: Q3 2025 222.7k, Q4 2025 222.7k, Q1 2026 222.7k, Q2 2026 222.7k
52 IMAGENEBIO INC COM IMA IMA 31,884 $188.1k0.01% 0.01% UnchangedShares held: Q3 2025 31.9k, Q4 2025 31.9k, Q1 2026 31.9k, Q2 2026 31.9k
53 HEARTFLOW INC COM HTFL HTFL 5,079 $149.0k0.01% 0.01% NewShares held: Q3 2025 0, Q4 2025 0, Q1 2026 0, Q2 2026 5.1k

Sold out since Q1 2026

SecurityTickerShares held beforeValue then
ASTRAZENECA PLC AZN AZN 456,031 $89.9m456.0k shares
BIOGEN INC BIIB BIIB 229,521 $42.1m229.5k shares
CELCUITY INC CELC CELC 366,175 $41.8m366.2k shares
BRIDGEBIO PHARMA INC BBIO BBIO 409,183 $30.4m409.2k shares
DEXCOM INC DXCM DXCM 393,576 $24.7m393.6k shares
XENON PHARMACEUTICALS INC XENE XENE 305,216 $17.7m305.2k shares
STRYKER CORPORATION SYK SYK 44,480 $14.6m44.5k shares
ROIVANT SCIENCES LTD ROIV ROIV 477,995 $13.2m478.0k shares
COMPASS THERAPEUTICS INC CMPX CMPX 2,056,161 $10.9m2.1m shares
ORIC PHARMACEUTICALS INC ORIC ORIC 679,578 $8.6m679.6k shares
TANGO THERAPEUTICS INC TNGX TNGX 395,081 $8.3m395.1k shares
AXOGEN INC AXGN AXGN 210,665 $7.0m210.7k shares
CYTOKINETICS INC CYTK CYTK 91,791 $6.0m91.8k shares
HARMONY BIOSCIENCES HLDGS IN HRMY HRMY 152,695 $4.3m152.7k shares
VAXCYTE INC PCVX PCVX 50,600 $2.9m50.6k shares
ESTABLISHMENT LABS HLDGS INC ESTA ESTA 33,930 $1.9m33.9k shares
ACADIA PHARMACEUTICALS INC ACAD ACAD 78,551 $1.7m78.6k shares
SOLENO THERAPEUTICS INC SLNO SLNO 14,689 $491.8k14.7k shares
ZYMEWORKS INC ZYME ZYME 1,610 $40.3k1.6k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ULTRAGENYX PHARMACEUTICAL IN RARE · Call RARECall 500,000 $16.7m500.0k shares Added
INTUITIVE SURGICAL INC ISRG · Call ISRGCall 40,000 $15.9m40.0k shares New
GLOBUS MED INC GMED · Call GMEDCall 200,000 $15.8m200.0k shares New
EXELIXIS INC EXEL · Put EXELPut 254,200 $13.8m254.2k shares Added